Apologies, iolaire, as I must be having some sort of brain fog, but to make sure I am understanding, you are in a J&J study that is not affiliated with Hopkins? Is that right? Who's conducting the study? The J&J vaccine is easily available (or, so I understand) here where I live, so I am seriously considering getting it, too. I can't see where it would hurt, but I think I'd talk to my clinic first.Please keep up updated on this! Thanks, and good luck!
I received the J&J shot (booster for me) yesterday, had a bit of a sore arm initially but it was mostly gone by the nighttime. I was unable to do the blood draw for the study prior to vaccination but they still want my blood two weeks after.
Excuse my bad typing.Have you seen this article? I saved it for future reference but now it is fitting to the question, MM.https://onlinelibrary.wiley.com/doi/10.1111/ctr.14245
This is older and more of a news story than scientific. But, in trials earlier on, SOT recipients were one of the groups earmarked for monoclonial antibody therapy:https://www.prnewswire.com/news-releases/hundreds-of-people-at-risk-for-severe-covid-19-avoid-hospitalization-with-new-treatment-301231079.htmlI will have to dig through all my stuff (lots...) but I recall one paper that stated pausing the use of mycophenolate was also part of the wider treatment program of hospitalized tx patients.
This is great news, iolaire, but I'm not sure what it means. Do you feel you are adequately protected now? How strong was your immune response?
It'll be 4 weeks since my second shot on Saturday and I'll be going in to get another test for anti-bodies that morning. I'm hoping they find some this time, but since I'm on 2 immunosuppresents now and had no sickness from either shot I'm not expecting any.